Form D · Biotechnology
SIMPORE INC
West Henrietta, NY · CIK 0001431967
Offering snapshot reported Jun 21, 2010 · SEC filing
- Reported sold
- Yet to sell Offering amount: $1M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 21, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Apr 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-143765
Source: Form D, filed Jun 21, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark S. Ain | Director |
| Phillippe Fauchet | Director |
| Ted Franceschi | Director |
| Thomas Gaborski | Director, Executive |
| James L. Mc Grath | Director, Promoter |
| Kevin Parker | Director |
| Richard D. Richmond | Director, Executive, Promoter |
| Geoff Rosenberger | Director |
| Christopher Striemer | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
150 Lucius Gordon Drive, Suite 100
West Henrietta, NY, 14586
West Henrietta, NY, 14586